Department of Orthopaedic Surgery, Gyeongsang National University Hospital, Jinju, Korea.
Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea.
J Korean Med Sci. 2018 Jan 22;33(4):e27. doi: 10.3346/jkms.2018.33.e27.
This study evaluated the prevalence of osteosarcopenia, as well as the relationship between one-year mortality and osteosarcopenia, as defined by criteria of the Asian Working Group on Sarcopenia in patients age 60 or older with hip fracture.
A total of 324 patients age 60 years or older with hip fracture were enrolled in this retrospective observational study. The main outcome measure was the prevalence of osteosarcopenia, as well as the relationship between osteosarcopenia and 1-year mortality. The diagnosis of sarcopenia was carried out according to the Asian Working Group on Sarcopenia. Whole body densitometry analysis was used for skeletal muscle mass measurement and muscle strength were evaluated by handgrip testing. Mortality was assessed at the end of 1-year. Cox regression analysis was utilized to analyze the risk factor of osteosarcopenia.
Of 324 patients with hip fracture, 93 (28.7%) were diagnosed with osteosarcopenia. In total, 9.0% died during the one-year follow-up. A one-year mortality of osteosarcopenia (15.1%) was higher than that of other groups (normal: 7.8%, osteoporosis only: 5.1%, sarcopenia only: 10.3%). Osteosarcopenia had a 1.8 times higher mortality rate than non-osteosarcopenia.
The present study demonstrates that the prevalence of osteosarcopenia is not rare, and has a higher mortality rate than the non-osteosarcopenia group at the 1-year follow-up period. This is the first study evaluating the relationship between mortality and osteosarcopenia in patients with hip fracture.
本研究评估了 60 岁及以上髋部骨折患者中亚洲肌少症工作组定义的骨肌减少症的患病率,以及骨肌减少症与 1 年死亡率之间的关系。
本回顾性观察性研究共纳入 324 例 60 岁及以上髋部骨折患者。主要观察指标为骨肌减少症的患病率,以及骨肌减少症与 1 年死亡率之间的关系。根据亚洲肌少症工作组的标准诊断肌少症。全身骨密度分析用于骨骼肌质量测量,握力测试用于评估肌肉力量。在 1 年末评估死亡率。Cox 回归分析用于分析骨肌减少症的危险因素。
324 例髋部骨折患者中,93 例(28.7%)被诊断为骨肌减少症。在总随访期间,有 9.0%的患者死亡。骨肌减少症的 1 年死亡率(15.1%)高于其他组(正常组:7.8%,骨质疏松症组:5.1%,肌少症组:10.3%)。骨肌减少症的死亡率比非骨肌减少症高 1.8 倍。
本研究表明,骨肌减少症的患病率并不罕见,在 1 年随访期间其死亡率高于非骨肌减少症组。这是第一项评估髋部骨折患者死亡率与骨肌减少症之间关系的研究。